8^th World Congress on Breast Cancer & Therapies July 16-17, 2018 Melbourne, Australia

Zhiqiang An is Professor of Molecular Medicine, the Robert A. Welch Distinguished University Chair in Chemistry, and Director of the Texas Therapeutics Institute at the UT Health Science Center at Houston. His laboratory focuses on breast cancer antibody drug resistance mechanisms and cancer antibody drug discovery Previously, he was Director of Biologics Research at Merck Research Laboratories. Dr. An received his Ph.D. degree from the University of Kentucky and his postdoctoral training at the University of Wisconsin-Madison. He is elected fellow of Society for Industrial Microbiology and Biotechnology (SIMB) and the American Academy of Microbiology (ASM).

Molecular Medicine

RAGHU S. PANDURANGI is the Founder, President & CSO: January 2012 to Current for Sci-Engi-Medco Solutions Inc. Engineering and Basic Science to Clinical Medicine in St Louis, USA and has 20 years of total scientific leadership in targeted drug development. Having Proven track record of directing and building strong multidisciplinary team (chemists, biologists, post doctoral fellows, technicians & students) for research and preclinical program, Led 2 Products for FDA/EMEA approval (analytics, CMCs for IND/NDA and taken 1 oligo based cancer therapeutic product from concept to Phase 1).

New cancer targets, Nanobiotechnology, Chemotherapy ,Radiation therapy, Targeted Therapy

Dr. D. Roukos has graduated from Athens University School of Medicine, Greece. He underwent specialist training in surgery at the J.W.Goethe-University Hospital in Frankfurt a.M., Germany where received his Doctorate (Dr.med). He moved back to Greece and since 1990 works at the Ioannina University School of Medicine.

Gastric Breast cancer,Nonlinear Experimentation, Next Generation Sequencing(NGS).

Dr. Constantine Dimitrakakis recieved his Ph.D. degree at National and Kapodistrian University of Athens and is currently an associate Professor Athens University Medical School, Athens, Greece. He has published (over 70 articles in PubMed Journals) mainly on the breast, laboratory and clinical studies on hormone therapy and breast cancer. Clinically based research on the role of androgens on breast cancer risk. Active member of the American Association of Cancer Research (AACR). Member of NIH FARE (fellow’s awards of research excellence) He is a Member of EUSOMA, EMAS, ESC and Greek Societies President of Greek Gynecologic Society of Breast Diseases (EGEPAM) Member of the Bioethics Committee of the Greek Ministry of Health Reviewer in noumerous scientific journals (The Breast, Journal of Clinical Endocrinology and Metabolism, BioMed Central journals etc.) Over 10 International Awards and numerous International Collaborations

Laboratory and clinically based breast research at the NIH, USA. Focus on the effects of Hormone Therapy on breast cancer risk and possible modifications of it.

The research in my laboratory is focused on understanding signaling networks within cells and how these signaling events modulate gene expression and proliferation. Extracellular signals are routed through signaling networks where they can activate multiple pathways, integrate at different levels, and form positive and negative feedback loops. The laboratory uses a combination of computational modeling and experimental biology to gain a systems understanding of the network and how it regulates gene expression and proliferation.

computational modeling to biochemical analysis of signaling events to proteomics using reverse phase high density lysate microarrays

Mufeed J. Ewadh has his expertise in many fields of biochemistry research in his institute dealing with health problem, herbal extraction, alternative medicine .He participated in many international and local conferences and workshops which deal with improvement of biochemical research to increase people awareness about its role. He participated in post doctorate course in Marburg University (Germany) on 2005 ,and he participated in electrophoresis workshop in japan for two weeks as well as in biochemical workshop in Leipzig (Germany) / 2016.His postgraduate supervision deals with many graduate students (M.Sc. and Ph.D.) which focus on publishing more than 140 papers in different local and international journals. His interest in publishing research paper made his institute to nominate him as the best professor for two years (2003),(2009) .He is chief in editor of most famous journal in Iraq (Medical Journal of Babylon ) and he got many rewards during his scientific life

Biochemistry